Twitter

Facebook

Youtube

RSS

Hindi News | Samay | UP/Uttarakhand | MP/Chhattisgarh | Bihar/Jharkhand | Rajasthan | Aalami Samay
  Rashtriya Sahara Roznama Sahara
Vaccine for children: Bharat Biotech awaits further regulatory approval
Last Updated : 12 Oct 2021 05:21:21 PM IST

 

Vaccine maker Bharat Biotech on Tuesday said that it is awaiting further regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for its Covid-19 vaccine Covaxin for the 2-18 years age group.

The Hyderabad-based company submitted data from clinical trials of the vaccine in the 2-18 years age group to CDSCO.
 
The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and have given their positive recommendations, the company said.
 
According to the form, this represents one of the first approvals worldwide for Covid-19 vaccines for the 2-18 age group.
 
"Bharat Biotech sincerely thank the DCGI, Subject Experts Committee, and CDSCO for their expedited review process. We now await further regulatory approvals from the CDSCO prior to product launch and market availability of Covaxin for children," it said.
 


IANS
Hyderabad
For Latest Updates Please-

Join us on

Follow us on


What binds the two most talked about nations - India and Pakistan together? What makes the

Bollywood actress Sonakshi Sinha is enjoying her marital bliss. On Monday, the actress too

LG Electronics Inc said on Wednesday that it will introduce new C with its artificial inte

 

Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live

172.31.16.186